DAA (direct acting antiviral)

31 October 2024. Related: D.

DAA (direct acting antiviral) – new hepatitis C drugs that work directly against the hepatitis C virus (HCV).

The following links are to UK prescribing information for DAA combinations plus ribavirin.

Elbasvir/grazoprevir
https://bnf.nice.org.uk/drugs/elbasvir-with-grazoprevir/

Sofosbuvir/ledipasvir
https://bnf.nice.org.uk/drugs/ledipasvir-with-sofosbuvir/

Glecaprevir/pibrentasvir
https://bnf.nice.org.uk/drugs/glecaprevir-with-pibrentasvir/

Sofosbuvir/velpatasvir
https://bnf.nice.org.uk/drugs/sofosbuvir-with-velpatasvir/

Ribavirin (RBV)
https://bnf.nice.org.uk/drugs/ribavirin/

Additional information is available from the MHRA website.
https://products.mhra.gov.uk/